Risk of Thrombosis After Stopping Anticoagulation in APS With aPL Negativization -JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Claire Kelly et al., adding:
”Thrombotic Recurrence After Anticoagulation Cessation in Patients with Antiphospholipid Syndrome and Antiphospholipid Antibody Negativization: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of 55 APS patients who discontinued anticoagulation following aPL negativization reports a pooled thrombotic recurrence rate of 1.61 per 100 person-years, suggesting that aPL negativization may warrant re-evaluation of long-term anticoagulation necessity in carefully selected low-risk patients.”
Title: Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Authors: Claire Kelly, Janet Cleary, Catriona Keenan, Isabelle Delachapelle, Leona Connolly, Mary Byrne, Mairead O’Donovan, Niamh M. O’Connell, James S. O’Donnell, Kevin Ryan, Michelle Lavin
Stay updated on all scientific advances with Hemostasis Today.
-
May 8, 2026, 17:35Gurpreet Kaur Sagoo: A Rare Bone Marrow Failure Syndrome That Challenges Early Diagnosis
-
May 8, 2026, 17:31Edward Lee Carter։ Stroke Prevention Starts in the Emergency Department – but Doesn’t End There
-
May 8, 2026, 17:14Hayder Kadhim: Determinants and Outcomes of OAC Discontinuation in Atrial Fibrillation
-
May 8, 2026, 17:11Drazen Perkov: Complication Management in Endovascular Thrombectomy
-
May 8, 2026, 17:07Basel Saber: New Evidence on Stroke Prevention in Post-Operative Atrial Fibrillation
-
May 8, 2026, 17:00Adriana Skafi: Case Report on Catastrophic Antiphospholipid Syndrome
-
May 8, 2026, 16:43Panagiotis Iliakis: The ANDAMAN Trial and the Challenge of Aspirin Resistance
-
May 8, 2026, 16:36Ali AlBahar: Why Blood Groups Matter
-
May 8, 2026, 16:27Tanmay Banerjee: Laboratory Error Safety in Hematology Testing